NEWSRELEASEFORIMMEDIATERELEASE:May16,2017

SharkletTechnologiesAnnouncesAcquisitionbyPeacefulUnionandNewPartnershiptoAccelerateDevelopmentofMedicalDevicesand

SurfaceTechnologiesFeaturingSharklet®AURORA,COLO.–SharkletTechnologies,Inc.,abiotechnologycompanylaudedforthecreationandcommercializationofSharklet®,theworld’sfirstmicro-texturethatinhibitsbacterialgrowthonsurfaces,todayannouncedthatithascompletedafinancingeventledbyPeacefulUnion,anequitymedicaldevicefirminHangzhou,China.Termsofthetransactionwerenotdisclosed.TheacquisitionofthecompanywillenableSharkletTechnologiestoacceleratethedevelopmentofSharkletformedicaldeviceswherechemical-freebacterialinhibitionisdesiredaswellashigh-touchsurfacespronetobacterialcontamination.Thecompanyalsowillacceleratedevelopmentofanewlyenhancedwounddressingtechnologytoencouragehealing.JoeBaganandMarkSpieckerledthetransactionstructure.“Thisisanimportantdayforthecompanyandinvestors,”saidJoeBagan,formerboardchair,andMarkSpiecker,formerCEO,“Ourinvestorswillrealizeasignificanttransactionwhileenablingthecompanytoaccelerategrowth.”Inconcertwiththeinvestment,SharkletTechnologiesfoundingmember,chieftechnologyofficer,andSharkletinventorDr.AnthonyBrennan,willbecomechairmanoftheboardassumingdutiesfromchairmanJoeBaganandCEOMarkSpiecker.“Today’seventmarksasignificantmomentinSharkletTechnologies’history.Tenyearsago,wediscoveredSharklet’sextraordinarycapabilitiesasanewwayofinhibitingmicroorganismgrowth,”saidDr.Brennan.“Sincethen,wehavepioneerednewmanufacturingmethodstobringthetechnologytomarketwiththeintentiontocreatecleanersurfaceswithoutchemistry.Wehavecontinuedprofoundopportunitytochangethewayweco-existwithmicroorganismsaroundus.WelookforwardtoinventingthenextchapterforSharkletTechnologiesandbringingSharklet-enhancedproductstomarket.”BrennaninspiredthefoundingofSharkletTechnologieswhenhisresearchattheUniversityofFloridarevealedthatamicroscopictexturemimickingsharkskinmaintainedmicroorganismgrowthinhibitionproperties.Themicro-textureiscomprisedofahighly-orderedseriesofbarsarrangedinaninterlockeddiamondpatternwhichcreatesasurfacethatmicroorganismsfindinhospitableforattachmentandgrowth.Thetechnologywasinventedformarineenvironmentstoaddressbiofoulingwithfunding

supportfromtheOfficeofNavalResearch.Later,theSharkletmicro-texturewasproveneffectiveininhibitingbacteriathatimpacthumanhealth.Toadvanceitsresearchanddevelopment,SharkletTechnologieswasarecipientofseveralSmallBusinessInnovationResearchgrantsthroughtheNationalInstitutesofHealthwhichprogressedprimaryresearchformedicaldevicesincludingSharkletapplicationonaurinarycatheterandanendotrachealtube.SinceSharkletTechnologieslicensedthetechnologyfromUniversityofFloridain2007,thecompanyhasfoundnumerousapplicationssuitablefortheintegrationofSharklettocreatecleanersurfaces.SharkletTechnologieswillmaintainitsheadquartersatBioscienceCenterParkCenter,abiotechnologyincubatorintheFitzsimonsLifeScienceDistrictadjacenttotherenownedAnschutzMedicalCampusinAurora,Colo.SharkletTechnologiesemploys20peopleincludingtheSharkletTechnologiesmanufacturingteamlocatedinChicagothatspecializesinnano-andmicro-structuredesignandmanufacturing.AboutSharkletTechnologies,Inc.SharkletTechnologiesisabiotechnologycompanythatdevelopssurfacetechnologiesthataredesignedtoinhibitmicroorganismgrowthtomaketheworldahealthier,environmentallysaferandbetterplace.Inspiredbythemicrobial-resistantpropertiesofsharkskin,Sharklet™,thecompany’scoretechnology,istheworld’sfirstmicro-texturedevelopedtocontrolbacteriaincludingStapha.,MRSA,VRE,E.coliandahostofothers.Sharkletissuitedforcommercial,healthcare,andhigh-touchenvironmentswherebacterialinhibitionisdesired.ThecompanyisbasedattheBioscienceParkCenter,anincubatorintheFitzsimonsLifeScienceDistrictadjacenttotherenownedAnschutzMedicalCampusinAurora,Colo.Moreatwww.sharklet.com.

###MediaContact:SarahEderPrimaveraGroupforSharkletTechnologies,Inc.sarah@theprimaveragroup.com303-887-9744direct